PARATAXIS ACQUIRES KOREA’S BRIDGE BIOTHERAPEUTICS TO LAUNCH BTC TREASURY PLATFORM

Parataxis Holdings has purchased Bridge Biotherapeutics for $18.5 million to enter Korea’s public markets with a Bitcoin treasury initiative.

The move signals a bold fusion of biotech and institutional crypto finance.

Source: @Cointelegraph